000282914 001__ 282914
000282914 005__ 20251218105736.0
000282914 0247_ $$2doi$$a10.1016/j.parkreldis.2025.108092
000282914 0247_ $$2pmid$$apmid:41385895
000282914 0247_ $$2ISSN$$a1353-8020
000282914 0247_ $$2ISSN$$a1873-5126
000282914 037__ $$aDZNE-2025-01375
000282914 041__ $$aEnglish
000282914 082__ $$a610
000282914 1001_ $$aSchneider, Zachary$$b0
000282914 245__ $$aAssessment of SLC25A46 variants in idiopathic Parkinson's disease.
000282914 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2025
000282914 3367_ $$2DRIVER$$aarticle
000282914 3367_ $$2DataCite$$aOutput Types/Journal article
000282914 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1766051780_31262
000282914 3367_ $$2BibTeX$$aARTICLE
000282914 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000282914 3367_ $$00$$2EndNote$$aJournal Article
000282914 520__ $$aRare damaging variants in the SLC25A46 gene were recently reported to be associated with optic atrophy and parkinsonism in compound heterozygous state. Here, we comprehensively investigated the role of SLC25A46 variation in idiopathic Parkinson's disease (PD) by leveraging whole genome sequencing (WGS) and genotyping imputed data from the Global Parkinson's Genetics Program (GP2) and the Accelerating Medicines Partnership for Parkinson's disease initiative (AMP-PD). Our analyses included genotyping imputed data from 19,573 PD cases and 11,748 neurologically healthy controls of European, African Admixed, African, East Asian, Ashkenazi Jewish, Middle Eastern, Central Asian, and Latino and Indigenous people of the Americas ancestries from GP2. Additionally, we mined WGS data from 924 PD patients and 229 healthy controls, as well as 3359 PD cases and 4153 neurologically healthy controls of European ancestry from GP2 and AMP-PD, respectively. Burden analysis of rare non-synonymous variants across case-control individuals from WGS data did not find evidence of SLC25A46 association with PD. Of the four SLC25A46 variants observed, the p.K256R variant previously reported by Bitetto et al. was found in 1/3359 controls and 1/4153 cases of European ancestry but its association was not significant. In addition, we identified p.E79K/p.V211M in 1/3359 controls and 1/4153 cases, without confirmation of a putative compound heterozygosity effect due to the lack of phasing data. This variant was also identified in Admixed American/Latin American, African Admixed, Ashkenazi Jewish, and Central Asian ancestries. However, no significant enrichment in cases versus controls was observed. Our results do not support a major role for SLC25A46 in idiopathic PD in the European population or other ancestries, though our imputation results require cautious interpretation for ultra-rare variants.
000282914 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000282914 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000282914 650_7 $$2Other$$aGenetics
000282914 650_7 $$2Other$$aParkinson's disease
000282914 650_7 $$2Other$$aRisk factor
000282914 650_7 $$2Other$$aSLC25A46
000282914 7001_ $$0P:(DE-2719)9001971$$aLiu, Hui$$b1
000282914 7001_ $$0P:(DE-2719)9002232$$aDehestani, Mohammad$$b2$$udzne
000282914 7001_ $$0P:(DE-HGF)0$$aMakarious, Mary B$$b3
000282914 7001_ $$aCrea, Peter Wild$$b4
000282914 7001_ $$aBandres-Ciga, Sara$$b5
000282914 7001_ $$0P:(DE-2719)2320009$$aGasser, Thomas$$b6$$udzne
000282914 7001_ $$0P:(DE-HGF)0$$aKim, Jonggeol J$$b7$$eLast author
000282914 7001_ $$aProgram, Global Parkinson's Genetics$$b8$$eCollaboration Author
000282914 773__ $$0PERI:(DE-600)2027635-7$$a10.1016/j.parkreldis.2025.108092$$gVol. 143, p. 108092 -$$p108092$$tParkinsonism & related disorders$$v143$$x1353-8020$$y2025
000282914 8564_ $$uhttps://pub.dzne.de/record/282914/files/DZNE-2025-01375%20SUP.docx
000282914 8564_ $$uhttps://pub.dzne.de/record/282914/files/DZNE-2025-01375_Restricted.pdf
000282914 8564_ $$uhttps://pub.dzne.de/record/282914/files/DZNE-2025-01375_Restricted.pdf?subformat=pdfa$$xpdfa
000282914 8564_ $$uhttps://pub.dzne.de/record/282914/files/DZNE-2025-01375%20SUP.doc
000282914 8564_ $$uhttps://pub.dzne.de/record/282914/files/DZNE-2025-01375%20SUP.odt
000282914 8564_ $$uhttps://pub.dzne.de/record/282914/files/DZNE-2025-01375%20SUP.pdf
000282914 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001971$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000282914 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002232$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000282914 9101_ $$0I:(DE-588)1065079516$$6P:(DE-HGF)0$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000282914 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2320009$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b6$$kDZNE
000282914 9101_ $$0I:(DE-588)1065079516$$6P:(DE-HGF)0$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b7$$kDZNE
000282914 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000282914 9141_ $$y2025
000282914 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-07
000282914 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-07
000282914 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-07
000282914 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-07
000282914 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-07
000282914 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-07
000282914 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-07
000282914 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bPARKINSONISM RELAT D : 2022$$d2025-01-07
000282914 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-01-07
000282914 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-01-07
000282914 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2025-01-07
000282914 9201_ $$0I:(DE-2719)1210000$$kAG Gasser$$lParkinson Genetics$$x0
000282914 980__ $$ajournal
000282914 980__ $$aVDB
000282914 980__ $$aI:(DE-2719)1210000
000282914 980__ $$aUNRESTRICTED